FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053490914> ?p ?o ?g. }

• W2053490914 endingPage "948" @default.
• W2053490914 startingPage "942" @default.
• W2053490914 abstract "OBJECTIVES: The long-term outcomes of oral antiviral therapy without hepatitis B immune globulin (HBIG) in prevention of reinfection with hepatitis B after liver transplantation are not known. We aimed to determine the long-term outcomes from a large population of chronic hepatitis B (CHB) liver transplant recipients using oral antiviral therapy alone. METHODS: A total of 362 consecutive CHB patients transplanted from January 2003 to May 2011 were included. None of the patients received HBIG. Viral serology, viral load, and liver biochemistry were performed at regular intervals during follow-up. RESULTS: Of the 362 patients, 176 (49%), 142 (39%), and 44 (12%) were on lamivudine (LAM), entecavir (ETV), and combination therapy (predominantly LAM+adefovir), respectively, at the time of transplant. The median follow-up length was 53 months. The rate of hepatitis B surface antigen seronegativity and hepatitis B virus (HBV) DNA suppression to undetectable levels at 8 years was 88 and 98%, respectively. The virological relapse rates (>1 log increase IU/ml) at 1, 3, 5, and 8 years was 5, 10, 13 and 16%, respectively. The virological relapse rate at 3 years for LAM, ETV, and combination group was 17, 0, and 7%, respectively (P<0.001). Forty-two patients had virological relapse, of which 36 had YMDD mutation (31 in the LAM group and 5 in the combination group). The overall 8-year survival was 83%, with no difference between the three treatment groups (P=0.94). No mortality from HBV recurrence occurred in the 362 patients. CONCLUSIONS: Oral nucleoside/nucleotide analogs without HBIG are effective in preventing graft loss secondary to hepatitis B recurrence after liver transplantation. However, new agents with a high barrier to resistance should be used to minimize drug resistance and to prevent virological rebound." @default.
• W2053490914 created "2016-06-24" @default.
• W2053490914 creator A5003029852 @default.
• W2053490914 creator A5014167223 @default.
• W2053490914 creator A5023277281 @default.
• W2053490914 creator A5040227760 @default.
• W2053490914 creator A5058347189 @default.
• W2053490914 creator A5063344656 @default.
• W2053490914 creator A5065005221 @default.
• W2053490914 creator A5066110089 @default.
• W2053490914 creator A5069529197 @default.
• W2053490914 creator A5073496328 @default.
• W2053490914 creator A5083700089 @default.
• W2053490914 creator A5091803938 @default.
• W2053490914 date "2013-06-01" @default.
• W2053490914 modified "2023-10-18" @default.
• W2053490914 title "Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B" @default.
• W2053490914 cites W1964467478 @default.
• W2053490914 cites W2017560695 @default.
• W2053490914 cites W2027490560 @default.
• W2053490914 cites W2043837365 @default.
• W2053490914 cites W2060781265 @default.
• W2053490914 cites W2066265094 @default.
• W2053490914 cites W2071904124 @default.
• W2053490914 cites W2091910482 @default.
• W2053490914 cites W2119566778 @default.
• W2053490914 cites W2122914734 @default.
• W2053490914 cites W2126836514 @default.
• W2053490914 cites W2142767881 @default.
• W2053490914 cites W2158084983 @default.
• W2053490914 cites W2167572870 @default.
• W2053490914 doi "https://doi.org/10.1038/ajg.2013.111" @default.
• W2053490914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23629601" @default.
• W2053490914 hasPublicationYear "2013" @default.
• W2053490914 type Work @default.
• W2053490914 sameAs 2053490914 @default.
• W2053490914 citedByCount "105" @default.
• W2053490914 countsByYear W20534909142013 @default.
• W2053490914 countsByYear W20534909142014 @default.
• W2053490914 countsByYear W20534909142015 @default.
• W2053490914 countsByYear W20534909142016 @default.
• W2053490914 countsByYear W20534909142017 @default.
• W2053490914 countsByYear W20534909142018 @default.
• W2053490914 countsByYear W20534909142019 @default.
• W2053490914 countsByYear W20534909142020 @default.
• W2053490914 countsByYear W20534909142021 @default.
• W2053490914 countsByYear W20534909142022 @default.
• W2053490914 countsByYear W20534909142023 @default.
• W2053490914 crossrefType "journal-article" @default.
• W2053490914 hasAuthorship W2053490914A5003029852 @default.
• W2053490914 hasAuthorship W2053490914A5014167223 @default.
• W2053490914 hasAuthorship W2053490914A5023277281 @default.
• W2053490914 hasAuthorship W2053490914A5040227760 @default.
• W2053490914 hasAuthorship W2053490914A5058347189 @default.
• W2053490914 hasAuthorship W2053490914A5063344656 @default.
• W2053490914 hasAuthorship W2053490914A5065005221 @default.
• W2053490914 hasAuthorship W2053490914A5066110089 @default.
• W2053490914 hasAuthorship W2053490914A5069529197 @default.
• W2053490914 hasAuthorship W2053490914A5073496328 @default.
• W2053490914 hasAuthorship W2053490914A5083700089 @default.
• W2053490914 hasAuthorship W2053490914A5091803938 @default.
• W2053490914 hasConcept C126322002 @default.
• W2053490914 hasConcept C142462285 @default.
• W2053490914 hasConcept C203014093 @default.
• W2053490914 hasConcept C2522874641 @default.
• W2053490914 hasConcept C2776175608 @default.
• W2053490914 hasConcept C2777382497 @default.
• W2053490914 hasConcept C2777869810 @default.
• W2053490914 hasConcept C2779517838 @default.
• W2053490914 hasConcept C2779609443 @default.
• W2053490914 hasConcept C2780056496 @default.
• W2053490914 hasConcept C2780593183 @default.
• W2053490914 hasConcept C2908647359 @default.
• W2053490914 hasConcept C2911091166 @default.
• W2053490914 hasConcept C71924100 @default.
• W2053490914 hasConcept C90924648 @default.
• W2053490914 hasConcept C99454951 @default.
• W2053490914 hasConceptScore W2053490914C126322002 @default.
• W2053490914 hasConceptScore W2053490914C142462285 @default.
• W2053490914 hasConceptScore W2053490914C203014093 @default.
• W2053490914 hasConceptScore W2053490914C2522874641 @default.
• W2053490914 hasConceptScore W2053490914C2776175608 @default.
• W2053490914 hasConceptScore W2053490914C2777382497 @default.
• W2053490914 hasConceptScore W2053490914C2777869810 @default.
• W2053490914 hasConceptScore W2053490914C2779517838 @default.
• W2053490914 hasConceptScore W2053490914C2779609443 @default.
• W2053490914 hasConceptScore W2053490914C2780056496 @default.
• W2053490914 hasConceptScore W2053490914C2780593183 @default.
• W2053490914 hasConceptScore W2053490914C2908647359 @default.
• W2053490914 hasConceptScore W2053490914C2911091166 @default.
• W2053490914 hasConceptScore W2053490914C71924100 @default.
• W2053490914 hasConceptScore W2053490914C90924648 @default.
• W2053490914 hasConceptScore W2053490914C99454951 @default.
• W2053490914 hasIssue "6" @default.
• W2053490914 hasLocation W20534909141 @default.
• W2053490914 hasLocation W20534909142 @default.
• W2053490914 hasOpenAccess W2053490914 @default.
• W2053490914 hasPrimaryLocation W20534909141 @default.

• next